"Today we take another step forward in our strategy to provide hospitals and clinicians with a full portfolio of solutions that address pressing healthcare needs," said Karen Licitra, Company Group Chairman and Worldwide Franchise Chairman for Ethicon Endo-Surgery. "Reprocessing has gained widespread acceptance and we will work to support SterilMed in meeting growing demand from customers. Together we will be able to continue meeting clinicians needs for high-performance medical devices, while also offering quality, cost-effective alternatives for hospitals to consider in order to help save money and reduce waste. This aligns strongly with our healthcare systems goals for transforming patient care and increasing affordability and access in the U.S."
SterilMed will continue to operate as a standalone company, focused on growing the market for single-use medical device reprocessing. SterilMed and EES will work together over the coming months to identify opportunities for growing the market to serve as many customers as possible.
In a separate press release, SterilMed announced the appointment of Mike Gustafson as Company President to succeed Brian Sullivan, who intends to retire from the company following a transition period. Gustafson will lead SterilMeds operating management team in working to sustain the companys growth trajectory and leverage its already successful business model.
About Ethicon Endo-Surgery
Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, develops and markets advanced innovative medical devices for minimally invasive and open surgical procedures, focusing on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. More information can be found at www.ethiconendosurgery.com.